BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/17/2022 3:19:27 AM | Browse: 920 | Download: 2417
Publication Name World Journal of Clinical Cases
Manuscript ID 72980
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Toripalimab combined with targeted therapy and chemotherapy perioperatively achieves pathologic complete response in gastric carcinoma: A case report
Manuscript Source Unsolicited Manuscript
All Author List Rui Liu, Xia Wang, Zhi Ji, Ting Deng, Hong-Li Li, Yan-Hui Zhang, Yu-Chong Yang, Shao-Hua Ge, Le Zhang, Ming Bai, Tao Ning and Yi Ba
ORCID
Author(s) ORCID Number
Rui Liu http://orcid.org/0000-0003-1287-2589
Xia Wang http://orcid.org/0000-0002-2935-0691
Zhi Ji http://orcid.org/0000-0002-2935-0692
Ting Deng http://orcid.org/0001-0002-2935-0694
Hong-Li Li http://orcid.org/0000-0002-8476-0936
Yan-Hui Zhang http://orcid.org/0002-0002-3546-0876
Yu-Chong Yang http://orcid.org/0000-0002-2935-0698
Shao-Hua Ge http://orcid.org/0001-0002-2935-7642
Le Zhang http://orcid.org/0001-0002-2935-0699
Ming Bai http://orcid.org/0000-0002-2935-0666
Tao Ning http://orcid.org/0000-0002-2935-0654
Yi Ba http://orcid.org/0000-0002-2935-0634
Funding Agency and Grant Number
Funding Agency Grant Number
Chinese Research Hospital Association Y2019FH-DTCC-SC3
Corresponding Author Rui Liu, Doctor, Chief Doctor, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, North Huanhu West Road, Sports Institute, Hexi District, Tianjin 300000, China. ruiliu688@126.com
Key Words Toripalimab; Targeted therapy; Chemotherapy; Perioperative management; Gastric carcinoma; Case report
Core Tip We report a case in which pathologic complete response was achieved by neoadjuvant administration of toripalimab, Herceptin, and docetaxel, oxaliplatin, calcium folinate, and fluorouracil chemotherapy followed by surgery for human epidermal growth factor receptor 2-positive and programmed death-ligand 1-positive locally advanced gastric carcinoma. We hope that this case will shed some light on neoadjuvant therapy for gastric carcinoma.
Publish Date 2022-06-17 03:19
Citation Liu R, Wang X, Ji Z, Deng T, Li HL, Zhang YH, Yang YC, Ge SH, Zhang L, Bai M, Ning T, Ba Y. Toripalimab combined with targeted therapy and chemotherapy achieves pathologic complete response in gastric carcinoma: A case report. World J Clin Cases 2022; 10(18): 6184-6191
URL https://www.wjgnet.com/2307-8960/full/v10/i18/6184.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i18.6184
Full Article (PDF) WJCC-10-6184.pdf
Full Article (Word) WJCC-10-6184.docx